# Bomedemstat (IMG-7289) in Combination With Momelotinib in Patients With Myelofibrosis

> **NCT07424950** · PHASE2 · NOT_YET_RECRUITING · sponsor: **United Lincolnshire Hospitals NHS Trust** · enrollment: 40 (estimated)

## Conditions studied

- Myelofibrosis

## Interventions

- **DRUG:** bomedemstat

## Key facts

- **NCT ID:** NCT07424950
- **Lead sponsor:** United Lincolnshire Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11-01
- **Primary completion:** 2028-11-01
- **Final completion:** 2029-11-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-20

## Collaborators

- University of Lincoln

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07424950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07424950, "Bomedemstat (IMG-7289) in Combination With Momelotinib in Patients With Myelofibrosis". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07424950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*